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Abstract
Background: Adipogenesis is the developmental process by which mesenchymal stem cells (MSC) differentiate
into pre-adipocytes and adipocytes. The aim of the study was to analyze the developmental strategies of human
bone marrow MSC developing into adipocytes over a defined time scale. Here we were particularly interested in
differentially expressed transcription factors and biochemical pathways. We studied genome-wide gene expression
profiling of human MSC based on an adipogenic differentiation experiment with five different time points (day 0,
1, 3, 7 and 17), which was designed and performed in reference to human fat tissue. For data processing and
selection of adipogenic candidate genes, we used the online database SiPaGene for Affymetrix microarray
expression data.
Results: The mesenchymal stem cell character of human MSC cultures was proven by cell morphology, by flow
cytometry analysis and by the ability of the cells to develop into the osteo-, chondro- and adipogenic lineage.
Moreover we were able to detect 184 adipogenic candidate genes (85 with increased, 99 with decreased
expression) that were differentially expressed during adipogenic development of MSC and/or between MSC and fat
tissue in a highly significant way (p < 0.00001). Subsequently, groups of up- or down-regulated genes were formed
and analyzed with biochemical and cluster tools. Among the 184 genes, we identified already known transcription
factors such as PPARG, C/EBPA and RTXA. Several of the genes could be linked to corresponding biochemical
pathways like the adipocyte differentiation, adipocytokine signalling, and lipogenesis pathways. We also identified
new candidate genes possibly related to adipogenesis, such as SCARA5, coding for a receptor with a putative
transmembrane domain and a collagen-like domain, and MRAP, encoding an endoplasmatic reticulum protein.
Conclusions: Comparing differential gene expression profiles of human MSC and native fat cells or tissue allowed
us to establish a comprehensive differential kinetic gene expression network of adipogenesis. Based on this, we
identified known and unknown genes and biochemical pathways that may be relevant for adipogenic
differentiation. Our results encourage further and more focused studies on the functional relevance of particular
adipogenic candidate genes.
Background
Human mesenchymal stem cells (MSC) are easy to iso-
late from bone marrow aspirates. In cell culture, they
can be expanded as clones showing multilineage differ-
entiation potential [1,2]. It is well known that human
MSC differentiate when cultured under appropriate
conditions into adipocytes, osteoblasts or chondrocytes
[1,3].
Human adipocyte development can be studied in vitro
starting from MSC cultures, which can be induced to
follow the process of adipogenesis [4]. How to grow
MSC obtained from bone marrow aspirates and other
tissues under adipogenic differentiation conditions [5,6]
is already well established. Insulin is known to act
through the insulin-like growth factor receptor 1. Dexa-
methasone, a synthetic glucocorticoid agonist is used to
stimulate the glucocorticoid receptor pathway and
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inhibitor, are used to raise the cAMP level and thus to
stimulate the cAMP dependent protein kinase pathway.
Here, we exposed cultured MSC to adipogenic condi-
tions in order to examine their adipogenic differentia-
tion potential by the observation of lipid droplets
stained with oil red O.
In recent years, new cellular and molecular insights
into adipogenesis have been obtained by combining
MSC as an in vitro model for adipogenic differentiation
and new “omics” technologies as monitoring tools.
Transcriptomics in combination with bio-informatics
were not only essential in providing a list of potential
adipogenic key player genes, they also allowed for a pre-
liminary global view on biological processes and mole-
cular networks involved in adipogenesis [7-9], whereas
proteomics of adipogenically differentiated MSC were
important to verify transcriptomic data [10]. Further-
more, epigenomic approaches have allowed deeper
insight in the epigenetic programming of MSC from
human fat tissue [11], and state-of-the-art microRNA
array technology revealed the influence of non-coding
RNA on MSC adipogenesis [12,13]. In particular, miR-
27a was found to be a negative regulator of adipogenesis
via the suppression of PPARG expression [13].
During adipogenesis derived from MSC, the gene
expression profile represents a unique, albeit not totally
deciphered, pattern of transcription factors, allowing for
the differentially induced regulation of specific pre-adi-
pogenic genes to form pre-adipocytes. These regulatory
factors promote further downstream target gene expres-
sion, responsible for the formation of typical adipocytes.
In vivo, adipose tissue consists of, for one half, classical
adipocytes, in which growth and long-term change and
storage of lipids and fatty acids can be observed. The
other half is composed of pre-adipocytes and supporting
cells such as fibroblasts, immune cells (macrophages) or
different blood cells [14]. It has been shown that adipo-
cytes cannot grow and accumulate lipids without restric-
tion: for example, after reaching a certain size they are
forced to divide into two or more adipocytes. The two
observed processes, called hypertrophy (increase in adi-
pocyte size) and hyperplasia (increase in adipocyte num-
ber) are typical observations of adipose tissue expansion
[15]. After initial expansion under standard culture con-
ditions, cellular growth arrest of proliferating pre-adipo-
cytes is stopped when reaching confluence. However,
following the addition of a hormonal cocktail, the cells
undergo further cell divisions. In most cases this phe-
nomenon occurs before the terminal differentiation pro-
gram starts, and development into mature adipocytes
begins.
The overall goal of our study was to analyze the pat-
tern of gene expression of human bone marrow MSC
differentiation into adipocytes during a defined time
scale. We were particularly interested in differentially
expressed transcription factors corresponding to bio-
chemical pathways involved in the process of adipogen-
esis. Therefore we report genome-wide gene expression
profiling of three human MSC lines on adipogenic dif-
ferentiation at five different time points (day 0, 1, 3, 7
and 17) in reference to normal human fat cell tissue.
Thereafter, the expression profiles of all cells were ana-
lyzed using the online SiPaGene database for Affymetrix
microarray expression data, which was set up for chip
comparison experiments [16]. With this approach, it
w a sp o s s i b l et od e s c r i b eas p e c i f i cp a t t e r no fg e n e
expression during adipogenic differentiation of human
MSC and between these MSC and native human fat
tissue.
Results
Isolation, culture and surface marker presentation of
human MSC
Human MSC were isolated from bone marrow aspirates
and expanded in standard culture media containing
selected batches of fetal bovine serum and 1 ng/mL
basic-FGF. Cultures showed the typical fibroblast-like
cell morphology of MSC growing in a swirling pattern
during primary culture (Figure 1-A) up to passage 3
(Figure 1-B). To verify cell identity, cells were routinely
investigated using flow cytometry analysis. Measure-
ments revealed a uniformly negative cell population for
the hematopoietic markers CD14, CD34 and CD45 (Fig-
ure 1-C), and positive for CD44, CD73, CD90, CD105
and CD166 (Figure 1-C).
Osteogenic, chondrogenic and adipogenic potential of
MSC
Expanded MSC were routinely tested for their multiline-
age potential by inducing these cells towards osteogenic,
chondrogenic and adipogenic differentiation. Osteogenic
differentiation could be demonstrated in the osteogen-
esis assay by staining for alkaline phosphatase (AP)
activity as well as by intense von Kossa staining of a cal-
cified bone matrix. On day 21, induced cultures showed
clear signs of enhanced AP activity (Figure 2-A) and
also an increased secretion of mineralized bone matrix
(Figure 2-C) compared to controls (Figures 2-B, D).
High-density micromass culture for chondrogenesis
resulted in the formation of cartilaginous extracellular
matrix as demonstrated by alcian blue staining of carti-
lage glycosaminoglycans (Figure 2-E) and antibody stain-
ing of cartilage-specific collagen type II (Figure 2-G). On
day 21, non-induced control cultures did not show
chondrogenic characteristics (Figures 2-F, H). Finally,
before performing microarrays of adipogenic induced
MSC, these cells were tested for their adipogenic
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Figure 1 Morphology and surface marker presentation of human MSC (A-C). Human mesenchymal stem cells (MSC) were isolated from
bone marrow aspirates. During primary culture (A) and up to passage 3 (B) they showed a typical fibroblast-like morphology and grew in a
swirling-like pattern. Flow cytometry analysis demonstrated a homogenous MSC population (C). As expected, MSC were negative for reactivity to
antigens CD14, CD34 and CD45, but positive for reactivity to antigens CD44, CD73, CD90, CD105 and CD166.
A D C B
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Figure 2 Osteogenic and chondrogenic differentiation of human MSC (A-H). On day 21, alkaline phosphatase staining of osteogenically
induced MSC cultures demonstrated an enhanced AP activity (A) when compared to control cultures (B). On this day, von Kossa staining of
osteogenically induced cultures was positive indicating a formation of mineralized bone matrix (C), whereas control cultures stained negative (D).
TGFb3 - induction of chondrogenesis, on day 21, resulted in the secretion of cartilage proteoglycans as shown by alcian blue staining (E), and of
cartilage specific collagen type II (G). Control cultures showed no secretion of both extracellular matrix molecules (F, H).
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days of growth in inducing media (Figure 3-A). Number
and size of the droplets increased over the cultivation
time of 21 days (Figure 3-B). Control cultures showed
no lipid droplet formation (Figure 3-C). As demon-
s t r a t e db yo i lr e dOs t a i n i n go fl i p i dd r o p l e t s ,t h e
induced cultures showed an increased accumulation of
cells with lipid droplets and the number and size of dro-
plets per cell had strikingly increased (Figures 3-D, E, F).
The adipocytic differentiation was monitored using flow
cytometry with different markers (Figure 4) - see also
Methods. After 14 days, expression of the mesenchymal
markers CD26, CD29, CD49b, CD55, CD73, CD90,
CD49f, CD120a and CD105 did not change or was
reduced comparing to the beginning and only expres-
sion of CD140a had increased [17].
Differential gene expression profiling of human MSC
during adipogenesis
To investigate the adipogenic differentiation program of
human MSC, we performed differential gene expression
profiling using the genome-wide Affymetrix GeneChip
technology. Three adult MSC donors and three native
fat cell donors were used in this study and up-loaded to
the online chip comparison database https://www.sipa-
gene.de/sipagene. We compared the gene expression
profiles of 3 individual group samples of adipogenically
induced P3 human MSC grown in adipogenic media
(passage 3) of days 1, 3, 7 and 17 with the undifferen-
tiated MSC samples of day 0 (36 pairwise chip compari-
sons). Additionally, we compared the gene expression
profiles of 3 samples of human fat tissues with the gene
expression profiles of the corresponding MSC on day 0
(9 pairwise chip comparisons). Comparative testing of
small groups is difficult. Using several statistical mea-
sures of the database at the same time, we tried to over-
come this limitation - for example the percentage of
increased or decreased change calls in all 3 × 3 = 9 pair-
wise comparisons between the individual chips of each
group, the mean of the SLR and the corresponding Fold
Change, p-values of 4 different t-tests and information
derived from Chip signal calculations including mean -,
median -, std - values (see also Methods) as well as pre-
sent calls. Candidate genes were selected based on sig-
nificance in t-test and increase or decrease - at least in
one group comparison, including present call in the
group of increased expression. Finally, five group com-
parisons (five experimental versus one baseline group)
were performed.
Subsequently, as part of a two-step approach (see
Methods), we identified genes with either consistently
increased or consistently decreased expression in each
of the five group comparisons and therefore are of inter-
est in the context of adipogenesis. Among the 54,675
probe-sets of the genome-wide GeneChips we found
184 genes to be differentially expressed in a highly
A B
D E
C
F
Figure 3 Adipogenic differentiation potential of human MSC (A-F). First the adipogenically induced human MSC lipid droplet formation
became visible at day 5 (A). The number and size was continuously increasing until day 15 (B). Control cultures, even at day 15, showed no lipid
droplet accumulation (C). Oil red O staining of lipid-droplets clearly confirmed adipogenesis at day 5 (D), 15 (E) and 20 (F).
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2). From this group 85 genes had increased expression
values (Additional file 1) and 99 genes showed
decreased expression values (Additional file 2), therefore
both files represent candidate genes of interest in adipo-
genic development.
To check for correct annotation of the target
sequences of the identified probe sets shown in Addi-
tional file 1 (increased values) and Additional file 2
(decreased values) we compared the sequences to entries
of the RefSeq release 46 using BLAST http://blast.ncbi.
nlm.nih.gov/Blast.cgi and Aligner (CodonCode Corpora-
tion). Most target sequences mapped with 100% match
to the 3’ end of the corresponding RefSeq entries for
mRNAs. For some probe sets the mapping indicated
that polyadenylation may occur upstream of the target
sequences, may include intron sequences or may even
locate outside of sequences referenced to known genes
and transcripts - see Additional file 3 - part A (increased
genes)/part B (decreased genes).
Finally, we confirmed by quantitative RT- PCR that
the gene expression of known adipogenic marker genes
were increased in adipocytes, generated not only from
primary layers, but also from strictly individualized
clones (Figure 5). The clonogenic cells generating the
clones were bonafide MSC since they were also able,
under appropriate conditions, to differentiate into osteo-
blasts and chondrocytes [2].
Cluster analysis of adipogenic gene expression profile
Hierarchical cluster analysis of genes was performed
using the clustering tool GENESIS. As shown in Figure
6, for all 184 differentially expressed genes, undifferen-
tiated MSC (day 0) clustered in one main group while
MSCs cultured under adipogenic conditions and the
native fat cell tissues clustered into another. This latter
group further sub-divided into two groups, one consist-
ing of MSC induced to differentiate into adipocytes, and
the other consisting of native fat tissue samples. The
group of adipogenic-induced MSC was also further sub-
divided into two groups, representing either MSC
induced for 1, 3, 7 or 17 days. Based on these 184 can-
didate genes, it was possible to detect striking differ-
ences in gene expression characteristic of adipogenic
differentiation. Gene clusters were found to discriminate
undifferentiated stem cells (day 0 of MSC) from early
committed cells (MSC cultured cells in adipogenic
media for 1-3 days), cells in an advanced stage of differ-
entiation/maturation (MSC cultured in an adipogenic
medium for 17 days), and fully differentiated adipocytes
(found in native fat tissues). Genes characteristic of the
different steps of differentiation are presented in detail
Figure 4 Control of adipocyte differentiation by FACS studies. The adipocytic differentiation was also monitored using flow cytometry with
different markers. After growing 14 days some of the cells were harvested and marked with the monoclonal antibodies CD26, CD29, CD49b,
CD55, CD73, CD90, CD140a (all Becton Dickinson, San Jose, CA), CD49f, CD120a (both Serotec, Raleigh, NC) and CD105 (Caltag, Buckingham, UK).
As a negative control, cells were incubated with the corresponding irrelevant mouse IgG1, IgG2a, IgG2b or IgGM mAbs - therefore, cells became
visible in the background. But only if a gene expression is changing in relation to the background after 14 days, can the result be positive. In
Figure 4 the cells were colored early in the beginning with a blue marker and after 14 days with a red coloration. Only mAb CD140a clearly
showed an increased gene expression after 14 days.
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experimental groups was not very high, further statisti-
cal analysis was performed only using mean values of
the genes with selectively increased and decreased
expression levels.
K-Means clustering and database - assisted biochemical
pathway analysis
For the 184 genes that were selected (Additional files 1
and 2), two different follow-up analysis strategies were
used: K-means clustering and biochemical pathway ana-
lysis. Applying K-means, 184 genes were clustered
according to a similar course of expression. The number
of clusters was estimated by Figure-of-Merit analysis
[18]. Sixteen different clusters could be determined,
each of them composed of 1-27 different genes. Apply-
ing this strategy, we directly compared all signal values
of various kinetic expression profiles. Here it was possi-
ble to analyze the expression status of human MSC dur-
ing adipogenesis and in comparison with native fat
tissue. Moreover, groups of genes with a similar expres-
sion profile could be identified (Figure 7, Figure 8).
It was also feasible to observe the expression profiles
of different cluster genes (known or unknown for invol-
vement in adipogenesis) and to find further early and
late stage adipogenesis marker genes with similar
qualities. For example, cluster 5 included the early stage
adipogenesis genes PPARG as well as ADIPOQ, while in
cluster 2 the very early stage adipogenesis gene PLIN,
but also IGF 1 was found. The difference between both
clusters was demonstrated by the classic kinetic shape
of their expression profiles. For the biochemical pathway
analysis, 85 increased expression adipogenic candidate
genes were loaded into the databases DAVID [19] and
KEGG [20], and then further divided into sub-groups (e.
g. DAVID) or just analyzed (e.g. KEGG and iHOP [21])
depending on their known function, such as PPARG sig-
nalling or fatty acid biosynthesis (Table 1). A few
strongly expressed candidate genes could not be inte-
grated into our group system according to their already
known biochemical function. Here of course it is inter-
esting to discuss their possible role during adipogenesis.
Sometimes, candidate genes with decreased expression
values do interact with known biochemical pathways,
but quite often we do not find a logical explanation in
terms of adipogenesis.
Therefore our main focus was on up-regulated genes:
only some of the decreased genes will be discussed here
a n da r es h o w ni nT a b l e1o ri nF i g u r e7a n d8 .M o s t
likely, these down-regulated genes inhibit or repress the
outcome of biochemical interactions during the process
of adipogenesis. In the following, we will highlight some
10+07
10+05
10+03
10+01
10-01
10-03
10-05
Figure 5 Quantitative RT- PCR-analysis. RNA from primary layers and clones was extracted before differentiation induction (day 0) and 14
days after addition of the adipogenic media. Here we tested the discussed adipogenic marker genes IGF 1, AOC3, PPARG, CEBPA, FASN, APOPE,
FABP4, LPL, PLIN, ADIPOQ and GHR for up-regulated expression using quantitative RT-PCR-technology. For gene names see Additional file 1.
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adipogenesis.
The PPAR-Gamma signalling pathway
We found at least three essential transcription factors of
the PPARG signalling pathway to be up-regulated: the
CCAAT/enhancer binding protein a (C/EBPA), the per-
oxisome proliferator activated receptor g (PPARG)a n d
the retinoid x receptor a (RXRA). We already identified
direct targets such as carboxylesterase 1 (CES1)a n d
Gycerol-3-phosphate dehydrogenase 1-like (GPD1)t ob e
up-regulated (see Table 1).
Additional genes implicated in adipogenesis
We also found up-regulation of at least three subse-
quent adipogenic target pathways: (1; Table 1) here just
called genes implicated in early adipogenesis, such as
the adipocyte differentiation pathway with the two
very early fatty acid binding proteins perilipin (PLIN)
and fatty acid-binding protein 4 (FABP4), as well as (2;
Table 1) adiponectin (ADIPOQ), a hormone which is
thought to be active further downstream in the adipo-
cytokine signalling pathway and, subsequently, in the
differentiation process. Furthermore, we found up-regu-
lated expression of genes involved in fatty acid transport
such as fatty acid transport with the hormone and
receptor protein apolipoprotein E (APOE)a sw e l la s
apolipoprotein L, 6 (APOL6), c o l l a g e n ,t y p eV ,- a l p h a3
(COL5A3), fibronectin leucine rich transmembrane pro-
tein 3 (FLRT3), lectin galactoside-binding, soluble, 3
(LGALS3)a n dc-type lectin domain family 1, member A
(CLEC1A) as well as the classic transport and reducing
enzyme lipoproteinlipase (LPL). We also detected up-
regulated expression of factors involved in triggering
lipogenesis (3; Table 1), such as stearoyl-CoA-desatur-
ase (SCD), acetyl-coenzyme A carboxylase beta
(ACACB), diacylglycerol-O-acyltransferase homolog 2
(DGAT2), fatty acid synthase (FASN), L-3-hydroxyacyl-
coenzyme A-dehydrogenase short chain (HADHSC), and
steroid 5 alphareductase 2-like (SRD5A2L).
The Insulin-like signalling pathway
Furthermore, genes encoding signalling cascades that are
involved in carbohydrate metabolisms as well as in cell
Figure 6 Hierarchical cluster analysis of adipogenic gene
expression profile. Hierarchical cluster analysis of the 184
candidate genes (85 with increased expression, 99 with decreased
expression) selected as relevant by SiPaGene. Clustering of genes
and experiments resulted in two main groups, namely
undifferentiated MSC at day 0 and all other experiments. The latter
main group was subdivided in the native fat tissue group and the
group of adipogenic induced MSC at day 1, 3, 7 and 17. The MSC
group was further divided in two groups: in the first, we found all
MSC cultures induced for 1 and 3 days (early adipogenesis) and 2
out of 3 MSC cultures induced for 7 days. In the second subgroup,
we observed all MSC cultures stimulated for 17 days (later
adipogenesis) and the third day 7 culture (see also the
dendrogram). Colours represent relative levels of gene expression:
bright red indicates the highest level of expression, and bright
green indicates the lowest level of expression. On the right site
gene names are included.
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up-regulated. Accordingly, during the observed time
period a strongly up-regulated expression was found for
the human MSC growth hormone receptor (GHR) as well
as for some transcription factors of the insulin-like sig-
nalling pathway (4, Table 1) such as the insulin-like
growth factor 1-somatomedin C (IGF1), insulin-like
growth factor 1 receptor (IGF1R), insulin induced gene 1
(INSIG1), insulin-like growth factor binding protein 5
(IGFBP5), and the insulin-like growth factor binding pro-
tein 7 (IGFBP7).
The Apoptosis pathway
We detected a whole set of apoptotic factors which were
up- or down-regulated during adipogenesis. Apoptosis
factors or modulators with increased expression during
adipogenesis were the activin A receptor type IC
(ACVR1C), complement component 7 (C7), PI-3-kinase-
related kinase SMG-1 (SMG1), CASP8 and FADD-like
apoptosis regulator (CFLAR), amine oxidase copper con-
taining 3 (vascular adhesion protein 1)( AOC3), cell
death-inducing DFFA-like effector c (CIDEC), DEAD
(Asp-Glu-Ala-Asp) box polypeptide 17 (DDX17), C1q
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Figure 7 K-Means cluster analysis of adipogenic gene expression profile. 184 candidate genes possibly associated with adipogenesis were
clustered into 16 different groups (C: Cluster) depending on the individual expression levels (K-means clustering method). The intensity is shown
by numbers on the left border, the expression levels are illustrated by means of the cluster images.
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and RNA binding motif protein 5 (RBM5). We also
found at least five apoptosis factors with decreased gene
expression including PRKC apoptosis WT1 regulator
(PAWR), BH3 interacting domain death agonist (BID),
mortality factor 4 like 2 (MORF4L2), heterogeneous
nuclear ribonucleoprotein C (C1/C2)( HNRPC)a n dsul-
fatase 1( SULF1).
Other molecules that have not yet been described in the
context of adipogenesis
Finally, new candidate genes coding for proteins and
possible regulatory factors, which may be related to the
adipogenesis of human MSC, have been identified. In
particular, strong up-regulation of gene expression was
found for the human receptor protein scavenger receptor
class A member 5-putative (SCARA5) with a putative
transmembrane domain and a collagen-like domain, and
the endoplasmic reticulum protein melanocortin 2 recep-
tor accessory protein (MRAP), and as well as some zinc
finger receptors (ATPases or GTPases) such as the pro-
teins IMAP family member 8 (GIMAP8).
Discussion
In this work we have isolated from bone marrow aspi-
rates human mesenchymal stem cells characterized by
their surface marker profile [1,17] and their osteogenic,
chondrogenic and adipogenic potential [5-7,22,23] to
study the expression profile of genes involved during
maturation and adipogenic differentiation. These cells
showed all the important characteristics of human MSC
and were further used for gene expression profiling ana-
lysis during adipogenic development. In studies of
human mesenchymal tissue development, the analysis of
expression of specific genes, carried out over a distinct
time period, is relevant to understanding the maturation
process. Since the applied cocktail of adipogenic indu-
cers, dexamethasone, 3-isobutyl-1-methylxanthine, indo-
methacin and insulin, was sufficient to promote
differentiation of human MSC to adipocytes, these MSC
were further used for gene expression profiling during
adipogenesis. Our data helped identifying gene sets
characterizing the sequential differentiation steps from
stem cells to fully differentiated adipocytes. In our
study, we observed differentially expressed genes coding
for molecules that have not yet been described in the
context of adipogenesis. For example the expression of
human receptor gene SCARA5 and the endoplasmic
reticulum protein gene MRAP were highly up-regulated,
suggesting new candidate genes effective in adipocytic
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Cluster analysis with corresponding adipogenic genes. 
Figure 8 Cluster analysis with corresponding adipogenic genes.
The number and names of the corresponding Cluster genes are
listed in Figure 8. It became possible to observe the expression
profiles of different cluster genes (known or unknown for
adipogenesis) and to find further early and late stage adipogenesis
marker genes with similar qualities. Detailed mean signal values of
human MSC at day 0, 1, 3, 7, 17 and of native fat tissue are also
given in Additional files 1 and 2.
Table 1 Adipogenic candidate genes and their involvement in biochemical pathways.
Pathway Candidate genes
PPARG signalling pathway Up-regulated:RXRA, C/EBPA, CES1, PPARG, GPD1
Adipocyte differentiation pathway Up-regulated:FABP4, PLIN
Adipocytokine signalling pathway Up-regulated:LPL, ADIPOQ, APOE, LGALS3, COL5A3,
APOL6, CLEC1A, FLRT3
Lipogenesis pathway Up-regulated:HADHSC, SCD, FASN, DGAT2,
SRD5A2L, ACACB
Insulin-like signalling pathway Up-regulated:IGFBP5, INSIG1, IGF1R, GHR, IGF1
Down-regulated:,IGFBP7
Apoptosis(factors related to, or no pathway) Up-regulated:ACVR1C, AOC3, C1QTNF1, C7, CFLAR, CIDEC, DDX17, LASP8, PI-3-kinase, RBM5, SMG1
Down-regulated:BID, HNRPC, MORF4L2, PAWR, SULF1
The 184 selected genes were analyzed in different online databases (DAVID, KEGG and iHOP), for example in gene studies and the gene products were
subsequently in biochemical pathway studies performed. Genes, up-regulated during adipogenesis were of most interest. This Table 1 shows pathways and
corresponding genes. For gene names and mean signal values see the Additional files 1 and 2. Charts that illustrate expression values as a function of time are
presented in Figure 7 and Figure 8.
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already described marker genes involved in adipogenesis
[4].
The PPARG signalling pathway has been intensively
studied over several years and scenario through which
various adipocyte transcription factors interact with adi-
pogenic target genes have already been proposed [24].
PPARG is a hormone receptor, which has already been
demonstrated to be the master regulator of adipogenesis
[25,26]. The dependent downstream-regulation cascade
can be controlled by PPARG itself or by PPARG in
combination with the controlling factor C/EBPA (also
up-regulated in our study).
It is very likely that C/EBPA and PPARG direct the
final phase of adipogenesis by activating expression of
adipocyte-specific genes, such as fatty acid synthetase,
fatty acid binding protein, leptin and adiponectin. How-
ever, the mainstream interaction between PPARG as
well as the RXRA receptor, another gene product was
found to be up-regulated during adipogenesis in our
study via ligand-binding, results in a conformational
change, namely in the formation of a special heterodi-
meric protein structure. The remaining functional
domain within the complex binds to various peroxisome
proliferator response elements (PPREs) and therefore
activates transcription of adipogenic target genes via
phosphorylation events, or, alternatively, causes induc-
tion of co-activator and co-repressor complexes [27,28].
It has been claimed that about 200 proteins can be con-
trolled by PPARG, probably via the PPARG-RXRA sig-
nalling pathway [29]. Therefore, it was not surprising
that various biochemical subgroups belonging to carbo-
hydrate metabolism, citrate cycle and energy transfer or
ion transport could be reformed on the basis of the
identified adipogenic candidate genes. Interestingly, we
found the PPARG target CES1, an enzyme located in
the endoplasmic reticulum and responsible for cellular
detoxification [30] to be highly up-regulated. Another
PPARG target example is presented by the addition of a
second GPD1 enzyme type. The PPARG-RXRA signal-
ling expression pattern leads to several additional down-
stream adipogenic target genes and corresponding
pathways, which are either up- or down-regulated [31].
Of course, we also found other up-regulated PPARG
targets, such as the transcripts coding for fatty acid-
binding FABP4 [32] and PLIN, which binds to fatty
acids in such a way that lipid droplets are formed and
fatty acids are protected against degrading enzymes [33].
Furthermore, the mobilization of the stored triglyceride
is thought to be controlled by interactions among intra-
cellular lipases during hormone-mediated lipolysis and
other proteins that coat lipid storage droplets [34]. In
our study, the mean value of PLIN was greatly increased
after 17 days as was that of the hormone ADIPOQ,
w h i c hi sa l s oak n o w nd o w n s t r e a mt a r g e to ft h e
PPARG-RXRA-regulator. Recently, PPARG has received
attention as a possible pharmacological target for the
thiazolidinedione class of anti-diabetic drugs as it is
essential for the final phase of adipocyte differentiation
and the pro-adipogenic effects of thiazolidinediones
have spurred interest in identifying therapeutic com-
pounds that retain anti-diabetic activity without promot-
ing adipogenesis. Inhibitors of PPARG activity that
reduces adipogenesis and thus serve as the basis for the
development of effective anti-obesity drugs [31] have
already been identified.
Further highly expressed genes (all named by the gene
name) were grouped together according to their known
biological function and pathway. The lipogenesis group
includes fatty acid synthase (FAS), which synthesizes
fatty acids (responsible for lipid accumulation). This
group also includes the enzymes ACACB, SRD5A2L,
HADHSC,a n dDGAT2. ACACB is a biotin-containing
enzyme, which catalyzes the carboxylation of acetyl-CoA
to malonyl-CoA, the rate-limiting step in the fatty acid
synthesis. But ACACB is also a complex multifunctional
enzyme system, which controls fatty acid oxidation
through the ability of malonyl-CoA to inhibit carnitine-
palmitoyl-CoA transferase I.
As expected we found the adipokine and adiponectin
metabolism (ADIPOQ) to be up-regulated. ADIPOQ
encodes a central cytokine, which is released by adipo-
cytes. It is involved in the control of fat metabolism and
insulin sensitivity, with direct anti-diabetic, anti-athero-
genic and anti-inflammatory activities. In the human
body, adiponectin stimulates the phosphorylation of the
AMP activated protein kinase (AMPK) in liver and the
skeletal muscle, antagonizes TNF-a by negatively regu-
lating its expression in various tissues such as liver and
macrophages, and also by counteracting its effects in
adipocytes by enhancing glucose utilization and fatty-
acid production [35]. The inhibitory potential of TNF-a
is mediated using the endothelial NF-kappa-B signalling
cAMP-dependent pathway [36,37]. ADIPOQ also plays a
role in cell growth, angiogenesis and tissue remodelling
by binding and sequestering various growth factors. It is
very likely that adiponectin interacts with one of the col-
lagens or is part of the extracellular matrix system [38].
At least one of the known collagen receptor genes,
COL5A3, was slightly up-regulated in our study. We
also detected the up-regulation of typical cell-cell signal-
ling factor genes with adhesive/cytokine like function,
such as CLEC1A and LGALS3. It has been shown that
LGALS3 can protect mitochondrial membrane integrity
and models suggested that it acts as an anti-apoptotic
factor, because it prevents cytochrome C release, thereby
blocking the effector stage of apoptosis [39]. It was dis-
cussed in literature that APOL6 can contribute to the
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branes and is therefore involved in mechanisms trigger-
ing programmed cell death [40]. In any case, the
regulator hormone ADIPOQ consists of a collagen
domain by itself and can pass through different cellular
membranes without any alteration of the domain.
ACACB is also part of the adipocytokine signalling path-
way and seems to play a central enzyme role in rats as
well as in man and alterations of the expression pattern
can possibly be responsible for obesity, diabetes [41],
and other metabolic pathway activities.
In addition, cytokines such as tumor necrosis factor
alpha (TNF-a) and other transforming growth factors
interfere with adipocyte differentiation. As expected, not
all typical examples for adipocytokines (e.g. leptins,
TNF-a, Interleukin-6 (IL6) or resistin) are expressed in
all types of tissues identically [42] - and some adipocyto-
kines were not found in this study. Nevertheless, we
detected members that are involved in the adipocyto-
kine-signalling pathway such as FLRT3,o fw h i c ht h e
protein product might also function as a receptor signal-
ling protein as well as a cell adhesion protein [43].
During the adipogenic maturation process, media con-
taining insulin may have resulted in the development of
insulin-independent mechanisms [44]. This phenom-
enon probably was the reason why the insulin-indepen-
dent cellular membrane receptor, which is called glucose
transporter-member 1 (GLUT1), was missing in our can-
didate gene list. Instead we found up-regulation of the
lipoprotein gene stomatin (STOM). Over-expression of
this lipoprotein often results in depressing the basal rate
of glucose transport by decreasing the intrinsic activity
of GLUT1 [45]. However, we also detected insulin-
dependent genes, such as INSIG1, which have been sug-
gested as a target of PPARG [4].
During adipogenic differentiation, we found that the
expression of IGFBP7 was down-regulated. The insulin-
like growth factor binding family is thought to modify
most IGF1 actions [46] and is very important for human
growth, while insulin by itself can bind to the IGF1
receptor to activate the phosphatidyl-inositol-3-phosphat
kinase (PI3K)/Akt (proteinkinase B)-signal mechanism
of the cellular structure [47]. However, a few members
of IGFBP family, such as IGFBP7, do have other bio-
chemical functions. For example IGFBP7 also binds
directly to insulin and in an artificial cell system it was
recently demonstrated that glioma cell growth can be
mediated by expressing IGFBP7 [48]. This observation
fits very well with our second finding, and therefore we
assume again that IGFBP7 has a negative effect on adi-
pocyte differentiation. IGFBP7 can modulate the stimu-
latory effect of vascular endothelial growth factors
(VEGF) on angiogenesis by interfering with VEGF
expression [49]. On the other hand, IGFBP5 is thought
to be associated with proteins of the extracellular matrix
(ECM) like fibronectin depending on bound molecules,
which might interfere with IGF1 and further growth
activities [46,49].
Strikingly, we detected increased expression of mem-
bers of the angiotensin II modulator family, such as the
angiotensin II type 1 receptor (AGTR1A)g e n e ,c o d i n g
for a receptor whose action is mediated by association
with G proteins, which activate the phosphatidylinositol-
calcium second messenger system. The human rennin-
angiotensin system can be activated by AGTR1A, while
angiotensin II is the main regulator or effector of the
cellular proliferation and survival [50]. Recently, many
publications demonstrated that tissue specificity is
achieved by modulation of the angiotensin receptor pro-
teins together with effector proteins [51], which would
fit well with our data and implies that AGTR1A is
involved in the adipocyte development. We also found
up-regulation of a further G protein-coupled receptor
gene, the cannabinoid receptor 1 (brain), called CNR1
[52]. The CNR1 receptor is the most abundant G pro-
tein-coupled receptor expressed in the brain. However,
CNR1 has also been detected in adipocytes, which is
consistent with our data, suggesting that CNR1 is
directly or indirectly effective on adipogenesis.
The regulatory factor lipopolysaccharide-induced TNF-
a factor (LITAF), which was down-regulated during adi-
pogenesis until day 17 and expressed at much lower
levels when compared with native fat cell tissue, might
play an important modifying role in TNF-a gene expres-
sion either through induction of lipopolysaccharides
(LPS) or via using the apoptotic TP53/p53 pathway.
Moreover, some fatty acids act as signalling molecules
regulating the differentiation into adipocytes or cell
death.
We also found up- or down-regulation of a number of
transcripts coding for factors implicated in apoptosis
such as LITAF, PRKC, PAWR, BID, MORF4L2,a n d
HNRPC. It has been shown very recently that LITAF is
a transcription factor, which plays an important role in
regulating the expression of TNF-a and various other
inflammatory cytokines in response to LPS stimulation,
negatively affecting adipocytic regulation [53], but this
observation still has to be confirmed. With our compari-
son approach we demonstrated that several other apop-
totic factors or mediators have been increased or
decreased during adipogenesis of human MSC. The
PAWR (PRKC, apoptosis, WT1, regulator)e x p r e s s i o n
was down-regulated as well. It has regulatory control
functions via down-regulating the B-cell lymphoma 2
(BCL-2) gene expression. The BH3 interacting domain
death agonist (BID) was also down-regulated and is
responsible for the release of mitochondrial cytochrome
c. Two further down-regulated transcription factor
Menssen et al. BMC Genomics 2011, 12:461
http://www.biomedcentral.com/1471-2164/12/461
Page 11 of 17candidates, which do both belong to a part of the apop-
tosis pathway, are the transcription factor genes mortal-
ity factor 4 like 2 (MORF4L2)a n dt h eheterogeneous
nuclear ribonucleoprotein C (C1/C2)( HNRPC).
We detected the up-regulation of genes, whose encod-
ing factors yet are unrelated to adipogenesis, such as
SCARA5 and MRAP. It is already known that SCARA5
is a ferritin receptor mediating non-transferrin iron
delivery, which is essential for cell growth [54], and that
MRAP might control cellular trafficking with the help of
other transmembrane proteins [55]. Our data suggest
their positive effect on adipogenesis, which should be
further investigated in gain and loss of function studies.
We also observed up-regulation of central genes coding
for enzymes of the glycolytic pathway such as hexoki-
nase 2 (HK2), which is integrated in mitochondrial
membranes instead of working in the cytosol [56], as
well as many stress proteins such as the peroxisome
control enzyme catalyze (CAT).
As a follow-up strategy it will be important to identify
regulatory networks related to specific transcription fac-
tors. Search tools like rVISTA [57] suggest further regu-
latory proteins or transcription factors based only on
potential binding sites upstream of the genomic
sequence of the named genes and calculate the probabil-
ity that individual binding sites are identified with a sig-
nificantly increased frequency. For example, the list of
our up-regulated candidates (Additional file 1) returned
GATA3, HFH3, AP4, FOXO4, POU6F1, FOXO1, GRE,
ISRE, LBP1, FOXP3 as potential candidates involved in
the regulation of these genes. However, this approach
can only generate hypotheses, which require further
confirmation by other techniques like chromatin immu-
noprecipitation followed by array hybridisation. It also
will be interesting to check, if some of the detected adi-
pogenic genes of the defined clusters or from one bio-
chemical group (see Table 1) perform a familiar pattern
of transcriptional regulation or to find de novo binding
strategies on the promotor site of the genes in further
experiments.
Conclusions
Adipogenesis is the developmental process by which
multipotent MSC differentiate into mature adipocytes.
We confirmed observations by others that several mole-
cular factors and biochemical pathways are involved in
this complex process of adipogenesis. However and to
go beyond the state-of-art, we analyzed the entire gene
expression profiles of human MSC during adipogenesis
over a defined time scale and compared the findings
with the expression profile of native fat cell tissue as a
reference. In this regard our emphasis was on differen-
tially expressed genes coding for key molecules and
transcription factors of fat cell development and on the
involvement of such factors in biochemical signalling
pathways. A battery of known (PPARG, C/EBPA and
RTXA) and new (SCARA5 and MRAP) adipogenic mar-
ker genes was found, and some of the newly identified
marker genes were linked to specific biochemical signal-
ling pathways.
Using the online chip database SiPaGene it was possi-
ble to establish a comprehensive kinetic gene expression
system and a network of adipogenesis genes, which
otherwise could only be found using multiple special
search approaches.
Methods
Isolation and expansion of human MSC
Human mesenchymal stem cells were isolated from iliac
crest aspirates obtained from informed and consenting
patients undergoing orthopedic surgery (Trousseau Hos-
pital, Tours, France) or diagnostic examinations (exam-
ined to exclude hematopoietic neoplasmas and
histologically diagnosed as normal; Charité-Universitäts-
medizin, Berlin, Germany), following a procedure
approved by the local ethical committees. As previously
described [17], nucleated cells were counted and seeded
at a density of 5 × 10
4 per cm
2 culture surface in a-
MEM (Invitrogen) supplemented with 10% (v/v)
screened fetal bovine serum (FBS), 1 ng/ml basic-fibro-
blast growth factor (basic-FGF; AbCys, Paris, France), 20
μmol/l L-glutamine (Invitrogen) and 100 units/ml peni-
cillin G (Invitrogen). Cells were incubated under stan-
dard culture conditions. On day 3, non-adherent cells
were removed by changing the medium; thereafter, the
medium was changed twice a week. After reaching con-
fluence, cells were trypsinized (0.25% v/v trypsin EDTA;
Invitrogen), re-suspended in culture media and seeded
at 1 × 10
3 cells per cm
2 (passage 1, P1). The isolation of
MSC clones was performed as previously described [2].
Isolation of native fat tissue
Fat tissue samples were harvested from three informed
and consenting patients with osteoarthritis of the knee
during joint replacement surgery from healthy areas of
normal subcutaneous fat tissue. The donation of fat tis-
sue was approved by the ethical committee of the Char-
ité-Universitätsmedizin Berlin.
Flow cytometry analysis
To verify the presentation of typical human MSC mar-
ker and a lack of remaining hematopoietic CD45
+ cells,
flow cytometry analysis was routinely performed on cul-
ture amplified human MSC. Cells were collected from
confluent layers at the end of P2 after incubation with
0.25% trypsin-EDTA for 5 minutes. Single-cell suspen-
sions were washed with phosphate buffered saline
(PBS)/0.5% bovine serum albumin (BSA) before staining.
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and re-suspended in cold PBS/0.5% BSA. 2.5 × 10
5 cells
were incubated for 15 minutes on ice in the dark in
cold PBS/0.5% BSA with titrated concentrations of R-
phycoerythrin (PE) conjugated monoclonal mouse anti-
human CD34, CD73, CD166 antibodies or monoclonal
fluorescein isothiocyanate (FITC) conjugated mouse
anti-human CD45, CD90, CD105 antibodies. All antibo-
dies except CD105 were purchased from BD-Pharmin-
gen (Heidelberg, Germany). Monoclonal CD105 was
purchased from Acris Antibodies (Hiddenhausen, Ger-
many). Cells were then washed twice by centrifugation
(250 g, 5 min) and re-suspended with cold PBS/0.5%
BSA, before proceeding with flow cytometry analysis.
Dead cells and debris were stained with propidium
iodide (100 μg/ml; Sigma-Aldrich, Taufkirchen, Ger-
many) and excluded from measurements. Acquisitions
were performed on a FACS Calibur flow cytometer
(Becton Dickinson) and data was analyzed using Cell-
Quest 3.3 software (Becton Dickinson) [17].
Verification of MSC multilineage potential
The multilineage differentiation potential of human
MSC (n = 3, P3) was analyzed by applying standard
protocols used by Pittenger et al. [1]. For adipogenesis
10,000 MSC/cm
2 were seeded. Five days after reach-
ing confluence, MSC were treated for three days with
induction media consisting of DMEM (4.5 g/l glucose;
Biochrom, Berlin, Germany) supplemented with 10%
FBS, 1 μM dexamethasone (Sigma-Aldrich), 0.2 mM
indomethacin (Sigma-Aldrich), 10 μg/ml insulin
(Actraphane, Novo Nordisk, Bagsvaerd, Denmark), 0.5
mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich),
and then for two days with maintenance media con-
s i s t i n go fD M E M( 4 . 5g / lg l u c o s e ) ,F B Sa n d1 0μg/ml
insulin.
This cycle of three days of induction and 2 days of
maintenance was repeated three times. Control cells
received only maintenance media. Osteogenesis was
induced for up to 28 days in Iscoves’s/DMEM/Ham’s
F12 medium (Biochrom) supplemented with 1% FBS,
100 nM dexamethasone, 10 mM b-glycerolphosphate
(Sigma-Aldrich) and 0.05 mM L-ascorbic acid 2-phos-
phate (AsAP; Sigma-Aldrich). Control cells were cul-
tured in media without the latter three substances. To
form high-density micromass cultures for chondrogenic
induction, 2 × 10
5 MSC were centrifuged and subse-
quently cultured for up to 28 days in a defined medium
consisting of DMEM (4.5 g/l glucose), ITS+1 (Sigma-
Aldrich), 100 nM dexamethasone, 0.17 mM AsAP, 1
mM sodium pyruvate (Sigma-Aldrich), 0.35 mM L-pro-
line (Sigma-Aldrich) and 10 ng/ml transforming growth
factor-b3( T G F b3; R&D Systems, Wiesbaden, Germany).
Controls were cultured without TGFb3.
Histological methods and immunohistochemistry
To demonstrate adipogenic differentiation, oil red O
(Sigma-Aldrich) staining of lipid droplets was per-
formed. To verify osteogenesis, visualization of alkaline
phosphatase activity with Sigma fast BCIP/NBT (Sigma-
Aldrich) and von Kossa staining (Sigma-Aldrich) of a
bone-specific mineralized matrix, was carried out. Chon-
drogenesis was shown by staining of cartilage proteogly-
cans with alcian blue 8GX (Roth, Karlsruhe, Germany)
counterstained with nuclear fast red (Sigma-Aldrich),
and by immunohistochemistry using the EnVision+Sys-
tem, Peroxidase rabbit kit AEC (Dako). Cryosections (6
μm) were incubated for 1 h with primary rabbit anti-
human type II collagen antibodies (Acris). Subsequently,
samples were treated according to the manufacturer’s
protocol and counterstained with hematoxylin (Merck,
Darmstadt, Germany).
RNA isolation and microarray analysis
To gain RNA for gene expression profiling, human MSC
from 3 different donors signed hBM19, hBM10, hBM9
(n = 3 donors, P1) were adipogenic stimulated for up to
17 days as described above. At day 0 (unstimulated
MSC), 1, 3, 7 and 17, total RNA was isolated applying
protocols of the RNeasy Mini Kit (Qiagen, Hilden, Ger-
many) including DNAse digestion. To isolate RNA from
three native fat tissues, 1 mg tissue was added to 1 ml
TriReagent (Sigma-Aldrich) and mechanically homoge-
nized using an Ultra-Turrax (IKA, Staufen, Germany).
Then the RNeasy Mini Kit was used for RNA isolation.
In general, the RNA was checked for integrity and pur-
ity with the Agilent Bioanalyzer (Agilent Technologies,
Böblingen, Germany) and NanoDrop spectrophotometer
(NanoDrop products, Wilmington, DE, USA).
Total RNA from each individual donor and sample was
used for genome-wide gene expression profiling. Hybridi-
zation on HG-U133 Plus 2.0 oligonucleotide microarrays
(in total 18 GeneChips) was performed according to stan-
dards supplied by the manufacturer (Affymetrix, Santa
Clara, CA, USA). In brief, cDNA was synthesized from 5
μg of total RNA and submitted to in vitro transcription
(ENZO, New York, NY, USA) to generate biotin-labelled
complementary RNA. 15 μg of the fragmented comple-
mentary RNA were hybridized to the GeneChips for 16
hours at 45°C. Arrays were washed and stained under
standardized conditions and scanned on a Hewlett Pack-
ard Genearray Scanner. Affymetrix GCOS 1.4 software
was used to control washing and scanning, to generate
DAT, CEL and EXP files and to process the raw data for
signal calculation and pairwise chip comparison [16].
Quantitative RT- PCR - analysis
RNA from primary layers and clones was extracted
before differentiation induction (day 0) and 14 days after
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lysed directly in the culture dishes and total RNA was
isolated using RNeasy Kit (Qiagen, Chatsworth, CL).
TaqMan low density arrays (Applied Biosystems, Foster
City, CA, http://www.appliedbiosystems.com) were used
in a typical quantitative two-step RT-PCR process as
previously described.
Gaining an adipogenesis expression profile of human
MSC
Initially, data obtained from all 18 microarray experi-
ments were processed with Affymetrix GCOS 1.4 soft-
ware. In pairwise chip comparison analyses each of the
three native fat tissue samples and of the three indivi-
dual adipogenic stimulated MSC cultures on day 1, 3, 7
and 17, were compared with each of the three not
induced MSC cultures on day 0 (5 [native tissue, adipo-
genic induced MSC on day 1, 3, 7, 17] × 3 [donors] × 3
[not induced MSC on day 0] = 45 pairwise chip
comparisons).
Subsequently, GCOS signal values, detection calls and
detection p-values (absolute data) as well as the signal log
ratios, change calls and change p-values (pairwise chip
comparison data) were uploaded into the online database
SiPaGene, where single group comparisons and gene
retrieval were performed [16]. This database has been
developed for the storage or exchange of Affymetrix Gene-
Chip microarray data and the performance of differential
gene expression experiments like comparing the imported
Affymetrix microarrays in special groups with each other
and starting different statistical analyses. Based on the
algorithms of the Affymetrix software and the Affymetrix
standard settings for integrated parameters like detection
call in case of chips and change call in case of pairwise
chip comparison, the speciality when performing the ana-
lysis with SiPaGene is to scale the Affymetrix signal values
using a target value of 150 for all arrays.
Our Affymetrix probe set annotation data set is always
adapted in parallel to the newest provided version (ver-
sion 46) - there is also an on-going discussion whether
oligonucleotide sequences should be remapped to the
latest genome build in order to avoid mistakes like
ambiguous probe matching.
In more detail, for each of the selected five group
comparisons (always consisting of one baseline group
with the three donors of a not induced MSC culture at
day 0 and of three experimental donors of either native
fat cells or adipogenesis induced MSC at day 1, 3, 7 and
17) new statistical values were generated. Corresponding
to the up-loaded Affymetrix data (absolute or compara-
tive data) for each group, we used the following
information:
the absolute signal, the mean value, the median value,
the standard deviation and the present detection call,
and for each group comparison as well, we used the
total signal log ratio (SLR) and the total fold change
(FC), the change call increase, the change call decrease
and the no change values were calculated. Furthermore,
Welch t-test analyses on signals between two groups as
well as on SLR values of pairwise comparisons of chips
within the same group or between groups were per-
formed as part of each group comparison.
Selection of candidate genes
With our strategy to perform the five different single
g r o u pc o m p a r i s o n s ,w et a r g e t e db u i l d i n gu pas p e c i a l
differential kinetic group comparison profiling during
adipogenesis. In this way, the progress of adipogenesis
could be examined, including native fat tissue as a refer-
ence tissue. But we used a two step-approach to identify
genes whose expression was increased or decreased in
each of the five group comparisons and which are there-
fore of interest in the context of adipogenic develop-
ment of human MSC. We expected that the gene
expression of our candidate genes would be significantly
increased or decreased in at least one comparison and
be present at each of the five group comparisons.
During the first step, adipogenesis selection para-
meters were utilized to select from all 54,675 probe-sets
of one comparison analysis, whereas during the second
step, the selected increased or decreased candidate
genes were analyzed in greater detail. Genes were
selected as relevant only when fulfilling the specific
standards. SiPaGene presents default query parameters
to select increased expression data sets or decreased
expression data sets. It also provides the usage of dis-
tinct query parameters for single group comparisons, for
example to determine the minimum false discovery rate.
In this study, we modified the queries for the default
parameters of increased and decreased expression and
compared as a very last step the findings with the
results in accordance with default parameters of mini-
mum false discovery (Bonferroni correction).
Concretely, we mainly analyzed the combination of
the different statistical values (e.g.: mean value, median
value) between the experimental group and the baseline
group and also took into account parallel further combi-
national values like the increased or decreased value. To
find genes whose expression was increased during adi-
pogenesis, we used SiPaGene default parameters but
additionally defined FC >= 2. Criteria for decreased
expression were also the already defined default para-
meters with the additional criteria FC <= -2. In addition,
the increased/decreased values had to be at least greater
than 50% and the p-values of different Welch t-test ana-
lysis at least <= 0.00001. All candidate genes were veri-
fied by repeating the data analysis, but using different
selection parameters or just default parameters of
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compared again with each other to remove double
genes or probe-sets and to eliminate false positives via
the Bonferroni correction.
Further characterization of candidate genes
Genes meeting all the criteria were further analyzed by
hierarchical clustering using GENESIS 1.7.2 software
[18]. To find if our genes or gene products are impor-
tant for adipogenesis, we loaded the list of relevant
genes into the online databases DAVID [19] and KEGG
[20], a resource linking genomes to life. Important infor-
mation we have also collected with the environment and
the literature research database iHOP [21].
In principle two main strategies were applied to detect
information about candidate genes with increased or
decreased expression. One possibility continued with
functional clustering or K-means value analysis (kinetic
comparison values) of gene clusters, while the second
approach started with biochemical pathway analysis.
Quite often we searched for unknown genes or tran-
scription factors, which showed a similar expression pat-
tern to factors belonging to an already described or
biochemical important pathway related to adipogenesis.
Using functional clustering it often becomes easy to find
unknown clusters of up- or down-regulated genes dur-
ing a large scale selection or better genes or groups of
genes, which lead to an identical biochemical pathway.
Although we had already done a pre-selection with
SiPaGene, we first used the cluster building strategy to
confirm our results and afterwards tried to find more
significant subgroups. Therefore all candidate genes
detected using the cluster building strategy were further
analyzed with help of public biochemical databases such
as DAVID and KEGG or via literature databases like
iHOP or in general with help from known scientific
literature.
Additional material
Additional file 1: Genes presenting increased expression values
during adipogenesis of human MSC. Candidate genes whose mean
signal expression values were increased during adipogenic development
of human MSC were selected with help of SiPaGene database. The mean
values of early (day 1 - day 3) or late (day 3 - day 7 - day 17 - fat)
adipogenesis candidate genes are given in comparison with day 0.
Affymetrix gene IDs are organized incrementally, in combination with a
SD-value (SD: Standard deviation). Using SiPaGene each of the five
performed MSC comparisons are working automatically with four
different t-tests (see Methods). Only the strongest p-value is included for
each ID and the most significant change (corresponding comparison) is
highlighted in the file.
Additional file 2: Genes presenting decreased expression values
during adipogenesis of human MSC. Candidate genes whose mean
signal expression values were decreased during adipogenic development
of human MSC were selected with help of SiPaGene database. The mean
values of early (day 1 - day 3) or late (day 3 - day 7 - day 17 - fat)
adipogenesis candidate genes are given in comparison with day 0.
Affymetrix gene IDs are organized incrementally, in combination with a
SD-value (SD: Standard deviation). Using SiPaGene each of the five
performed MSC comparisons are working automatically with four
different t-tests (see Methods). Only the strongest p-value is included for
each ID and the most significant change (corresponding comparison) is
highlighted in the file.
Additional file 3: Table S1 (increased genes) and Table S2
(decreased genes). Controlling of Affymetrix probe set annotation.
Control for the correct annotation of target sequences (which is not
shown) for Affymetrix probe sets shown in the Additional file 1
(increased genes) and Additional file 2 (decreased genes). Target
sequences were compared to entries of the RefSeq release 46 using
BLAST http://blast.ncbi.nlm.nih.gov/Blast.cgi and Aligner (CodonCode
Corporation). Most target sequences mapped with 100% match to the 3’
end of the corresponding RefSeq entries for mRNAs.
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